EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines

Nelli S Khudainazarova, Dmitriy L Granovskiy, Olga A Kondakova iD, Ekaterina M Ryabchevskaya iD, Angelina O Kovalenko iD, Ekaterina A Evtushenko iD, Marina V Arkhipenko, Nikolai A Nikitin iD, Olga V Karpova iD

International Journal of Molecular Sciences · 07.11.2024 · 25 (22) · 11979

DOI: 10.3390/ijms252211979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.11.2024. Verfasst von Nelli S Khudainazarova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Antigens, Viral, Viral Vaccines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review addresses the ongoing global challenge posed by emerging and evolving viral diseases, underscoring the need for innovative vaccine development strategies. It focuses on the modern approaches to creating vaccines based on recombinant proteins produced in different expression systems, including bacteria, yeast, plants, insects, and mammals. This review analyses the advantages, limitations, and applications of these expression systems for producing vaccine antigens, as well as strategies for designing safer, more effective, and potentially ‘universal’ antigens. The review discusses the development of vaccines for a range of viral diseases, excluding SARS-CoV-2, which has already been extensively studied. The authors present these findings with the aim of contributing to ongoing research and advancing the development of antiviral vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, ViralViral VaccinesHumansAnimalsRecombinant ProteinsProkaryotic CellsVaccine DevelopmentBacteriaPandemicsSARS-CoV-2

Stichwörter der Autor:innen

antigen designbiopharmaceutical productionexpression systemrecombinant antigenrecombinant proteinrecombinant vaccine platformssubunit vaccinesvaccine antigenvaccine developmentvirus-like particles

Substanzen

Antigens, ViralViral VaccinesRecombinant Proteins

Autor:innen und Institutionen

  • Department of Virology, Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.

ORCID-Profile: Olga A Kondakova, Ekaterina M Ryabchevskaya, Angelina O Kovalenko, Ekaterina A Evtushenko, Nikolai A Nikitin, Olga V Karpova

Förderung

  • Russian Science Foundation

Zitieren

APA

Khudainazarova, N. S., Granovskiy, D. L., Kondakova, O. A., Ryabchevskaya, E. M., Kovalenko, A. O., Evtushenko, E. A., Arkhipenko, M. V., Nikitin, N. A., & Karpova, O. V. (2024). Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines. International Journal of Molecular Sciences, 25(22), 11979. https://doi.org/10.3390/ijms252211979

Vancouver

Khudainazarova NS, Granovskiy DL, Kondakova OA, Ryabchevskaya EM, Kovalenko AO, Evtushenko EA, et al. Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines. International Journal of Molecular Sciences. 2024;25(22):11979. doi:10.3390/ijms252211979

BibTeX
@article{Khudainazarova2024,
  author = {Khudainazarova, Nelli S and Granovskiy, Dmitriy L and Kondakova, Olga A and Ryabchevskaya, Ekaterina M and Kovalenko, Angelina O and Evtushenko, Ekaterina A and Arkhipenko, Marina V and Nikitin, Nikolai A and Karpova, Olga V},
  title = {Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {22},
  pages = {11979},
  doi = {10.3390/ijms252211979}
}
Kostenlos starten →